GPCRStructure Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Structure Therapeutics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GPCRThis | $7.4B#8 | — | 5.5x#2 | — | — | -15.2%#11 | — | -10.4%#8 | — | — | 49.5%#9 | — |
| ARWR | $9.5B#1 | — | 20.4x#9 | 11.5x#4 | 23258.2%#1 | 99.7%#3 | 11.9%#4 | -0.4%#5 | — | — | 113.6%#6 | — |
| PTGX | $9.2B#2 | 138.6x#6 | 11.0x#6 | 200.8x#11 | -89.4%#12 | -147.3%#15 | -343.6%#11 | -15.5%#10 | -36.7%#6 | — | 129.6%#5 | — |
| TGTX | $8.6B#3 | 20.6x#2 | 14.3x#7 | 14.0x#7 | 87.3%#4 | 1811.1%#1 | 20.0%#1 | 74.0%#2 | 14.2%#2 | — | — | — |
| PRAX | $8.5B#4 | — | 6.3x#4 | — | -100.0%#13 | -65.6%#14 | — | -22.6%#11 | — | — | 569.5%#1 | — |
| SYRE | $8.1B#5 | 6.7x#1 | 7.3x#5 | — | — | 25.4%#8 | — | -14.1%#9 | — | — | — | — |
| ALKS | $7.7B#6 | 120.0x#5 | 4.2x#1 | 5.2x#2 | -5.2%#9 | -34.2%#13 | 17.2%#2 | 13.4%#3 | 7.5%#3 | — | 59.6%#8 | — |
| IONS | $7.6B#7 | — | 17.2x#8 | 8.0x#3 | 33.8%#7 | 16.0%#10 | -40.4%#9 | -86.7%#13 | -20.6%#5 | — | -26.1%#13 | — |
| RYTM | $6.8B#9 | — | 65.7x#11 | 35.6x#8 | 45.8%#6 | 24.6%#9 | -101.2%#10 | -0.2%#4 | -133.8%#7 | — | -0.3%#11 | — |
| ORKA | $6.4B#10 | — | 5.8x#3 | — | — | -25.9%#12 | — | -9.5%#7 | — | — | 484.7%#2 | — |
| MIRM | $6.3B#11 | — | — | 12.0x#5 | 54.7%#5 | 73.4%#5 | -4.2%#5 | — | — | — | 27.8%#10 | — |
| LQDA | $6.0B#12 | 48.3x#4 | 31.0x#10 | 38.2x#9 | 1031.2%#2 | 47.1%#7 | -32.5%#8 | -35.3%#12 | — | — | 173.9%#3 | — |
| TVTX | $6.0B#13 | — | 246.3x#13 | 12.3x#6 | 110.5%#3 | 92.1%#4 | -12.8%#6 | -104.2%#14 | — | — | 164.9%#4 | — |
| GOSS | $5.9B#14 | — | — | 122.6x#10 | -57.7%#11 | -201.4%#16 | -352.2%#12 | — | — | — | -95.1%#14 | — |
| AMRX | $5.9B#15 | 38.2x#3 | 177.5x#12 | 1.9x#1 | 8.0%#8 | 161.6%#2 | 13.1%#3 | 218.2%#1 | 14.6%#1 | 6#1 | 87.1%#7 | — |
| AMRN | — | — | — | — | -6.5%#10 | 55.4%#6 | -23.5%#7 | -8.7%#6 | -16.2%#4 | — | -7.9%#12 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice